You just read:

Daiichi Sankyo Initiates Pivotal Phase 2 Study of DS-8201 in Patients with HER2-Positive Advanced Gastric Cancer

News provided by

Daiichi Sankyo Company, Limited

20 Nov, 2017, 13:00 GMT